SYP

Chr X

synaptophysin

Also known as: MRX96, MRXSYP, XLID96

This gene encodes an integral membrane protein of small synaptic vesicles in brain and endocrine cells. The protein also binds cholesterol and is thought to direct targeting of vesicle-associated membrane protein 2 (synaptobrevin) to intracellular compartments. Mutations in this gene are associated with an X-linked form of cognitive disability. [provided by RefSeq, Jul 2017]

ResearchGenerating clinical summary…
LOFmechanismLOEUF 0.39
Clinical SummarySYP
🧬
Gene-Disease Validity (ClinGen)
non-syndromic X-linked intellectual disability · XLModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.92). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
9 unique Pathogenic / Likely Pathogenic· 66 VUS of 123 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.39LOEUF
pLI 0.915
Z-score 2.99
OE 0.08 (0.030.39)
Highly constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.33Z-score
OE missense 0.67 (0.560.80)
87 obs / 129.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.08 (0.030.39)
00.351.4
Missense OE?0.67 (0.560.80)
00.61.4
Synonymous OE?1.18
01.21.6
LoF obs/exp: 1 / 12.3Missense obs/exp: 87 / 129.8Syn Z: -1.09
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveSYP-related intellectual developmental disorder, X-linkedLOFXLR

This gene — mechanism propensity

DN
0.5082th %ile
GOF
0.6736th %ile
LOF
0.53top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF89% of P/LP variants are LoF · LOEUF 0.39
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

123 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic8
VUS66
Likely Benign16
Benign2
Conflicting2
1
Pathogenic
8
Likely Pathogenic
66
VUS
16
Likely Benign
2
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
0
0
0
1
Likely Pathogenic
7
1
0
0
8
VUS
4
58
3
1
66
Likely Benign
0
6
2
8
16
Benign
0
0
0
2
2
Conflicting
2
Total126551195

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

69 pathogenic / likely-pathogenic (of 77) ClinVar copy-number / structural variants overlap SYP — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

SYP · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.